Back
MercadoLibre Vs. Akero Therapeutics Industry Stock Comparison
Sell
47
MELI
MercadoLibre
Last Price:
$1,946.25
Seasonality Move:
14.78%
Buy
57
AKRO
Akero Therapeutics
Last Price:
$55.30
Seasonality Move:
-13.54%
Sell
47
MercadoLibre (MELI)
is a Sell
Is MercadoLibre a Buy, Sell or Hold?
-
The current MercadoLibre [MELI] share price is $1,889.76. The Score for MELI is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
MELI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.00. The Score for AKRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MELI Stock Price Chart
What is MercadoLibre's stock price today?
-
The MercadoLibre share price today is $1,889.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MELI is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
MELI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.25 | Buy |
Relative Strength Index (14 RSI): | 59.94 | Buy |
Chaikin Money Flow: | 44334 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1731.86 - 1844.38) | Buy |
Bollinger Bands (100): | (1816.62 - 2075.72) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.24 | Buy |
Relative Strength Index (14 RSI): | 85.85 | Buy |
Chaikin Money Flow: | 423269 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.76 - 38.18) | Buy |
Bollinger Bands (100): | (24.88 - 34.36) | Buy |
MELI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1849.06 | Buy |
20-day SMA: | 1802.56 | Buy |
50-day SMA: | 1850.84 | Buy |
200-day SMA: | 1815.65 | Buy |
8-day EMA: | 1852.22 | Buy |
20-day EMA: | 1825.43 | Buy |
50-day EMA: | 1849.96 | Buy |
200-day EMA: | 1810.8 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.66 | Buy |
20-day SMA: | 29.67 | Buy |
50-day SMA: | 29.97 | Buy |
200-day SMA: | 26.38 | Buy |
8-day EMA: | 39.78 | Buy |
20-day EMA: | 32.93 | Buy |
50-day EMA: | 30.49 | Buy |
200-day EMA: | 28.24 | Buy |
MercadoLibre Earnings Growth & MELI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.96 per share, and an increase next year of $18.19 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and an increase next year of $0.08 per share.
MercadoLibre Technical Analysis
Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |